BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 7054735)

  • 1. Current status of intrauterine devices. II. Intrauterine devices and pelvic inflammatory disease and ectopic pregnancy.
    Malhotra N; Chaudhury RR
    Obstet Gynecol Surv; 1982 Jan; 37(1):1-8. PubMed ID: 7054735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low risk of pelvic inflammatory disease in young never-pregnant women using Gravigard.
    Larsson B; Hagström B; Viberg L; Anker C; Hamberger L; Lindhe BA
    Contraception; 1979 Sep; 20(3):291-5. PubMed ID: 509955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with today's IUDs.
    Pasquale S
    Obstet Gynecol Surv; 1996 Dec; 51(12 Suppl):S25-9. PubMed ID: 8972499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine devices and pelvic inflammatory disease: an international perspective.
    Farley TM; Rosenberg MJ; Rowe PJ; Chen JH; Meirik O
    Lancet; 1992 Mar; 339(8796):785-8. PubMed ID: 1347812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
    Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
    Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postpartum IUDS: keys for success.
    O'Hanley K; Huber DH
    Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine contraceptive devices. Complications associated with their use.
    Nagel TC
    Postgrad Med; 1983 Mar; 73(3):155-64. PubMed ID: 6828391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine contraceptive devices and risk of pelvic inflammatory disease: standard of care in high STI prevalence settings.
    Steen R; Shapiro K
    Reprod Health Matters; 2004 May; 12(23):136-43. PubMed ID: 15242222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rise and fall and rise of the IUD.
    Burnhill MS
    Am J Gynecol Health; 1989; 3(3-S):6-10. PubMed ID: 12285000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine devices and pelvic inflammatory disease: recent developments.
    Grimes DA
    Contraception; 1987 Jul; 36(1):97-109. PubMed ID: 3311628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic inflammatory disease and the intrauterine contraceptive device.
    Wright EA; Aisien AO
    Int J Gynaecol Obstet; 1989 Feb; 28(2):133-6. PubMed ID: 2563699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern intra-uterine devices.
    Odlind V
    Baillieres Clin Obstet Gynaecol; 1996 Apr; 10(1):55-67. PubMed ID: 8736722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
    Larsson B; Rodau S; Patek E
    Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine contraceptive device use and pelvic inflammatory disease.
    Kaufman DW; Shapiro S; Rosenberg L; Monson RR; Miettinen OS; Stolley PD; Slone D
    Am J Obstet Gynecol; 1980 Jan; 136(2):159-62. PubMed ID: 7352496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine contraceptive device and pelvic inflammatory disease.
    Toivonen J
    Ann Med; 1993 Apr; 25(2):171-3. PubMed ID: 8489756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.